PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

UCLB, Apollo secure first licensing deal with US investment powerhouse

UCL Business (UCLB) and Apollo Therapeutics have secured their first out-licensing deal to US healthcare investment firm Deerfield. The deal will see a novel gene ...
Continue Reading →
News

Trainee GP numbers rise for third year running

New data released by Health Education England (HEE) show there were 3,441 GP specialty training places were accepted in 2020, compared to 2,891 a year ago. With on...
Continue Reading →
News

New data shows steep rise in people waiting for cancer tests

Alarm bells are ringing again over the impact of the COVID-19 pandemic on cancer care in the UK, after Cancer Research UK unveiled new data showing a steep rise in t...
Continue Reading →
News

BMS rolls cancer survivor campaign with TV actor spokesman and a new mission

Bristol Myers Squibb has enlisted actor Sterling K. Brown for a new program that aims to address the needs of an ever-increasing number of cancer survivors. As par...
Continue Reading →
News

AstraZeneca scores speedy FDA review for Farxiga based on ‘innovative’ heart attack trial design

AstraZeneca has already taken impressive Farxiga heart failure outcomes results and parlayed them into a watershed approval. Looking at Farxiga's future in a competi...
Continue Reading →
News

Tecentriq misses mark in ovarian cancer trial

Roche and Genentech's Tecentriq (atezolizumab) has failed to hit its primary goal in a late stage trial involving patients with newly diagnosed advanced stage ovaria...
Continue Reading →
News

UK report finds low awareness of non-melanoma skin cancer

Public awareness in the UK about non-melanoma skin cancer (NMSC) is 'worryingly low' and 'urgent action' is needed to improve sun protection for outdoor workers, con...
Continue Reading →
News

Study indicates lockdown significantly reduced coronavirus

The largest study to date examining rates of coronavirus infection in the general public has found that there was a significant reduction of the virus before lockdow...
Continue Reading →
News

Radiotherapy in fewer doses safe for early breast cancer

Giving fewer but larger doses of radiotherapy is as safe in the long term for breast cancer treatment, according to the final results of a 10-year study. According...
Continue Reading →
News

FDA committee backs GSK’s multiple myeloma drug

GlaxoSmithKline's belantamab mafodotin has been backed for approval to treat relapsed/refractory multiple myeloma by the US Food and Drug Administration (FDA) Oncolo...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026